SAN DIEGO – Consistent use of the mySugr app provides an opportunity for improved blood glucose control in high risk populations, according to a retrospective observational clinical research study by mySugr and ProSciento, Inc.
“The use of digital health apps continues to grow at a rapid rate, but their scientific impact on a patient’s therapy has remained largely unvalidated,” said Frank Westerman, CEO of mySugr. “We feel obligated to invest in scientific research to better understand the effect my Sugr has on our users therapy.”
The study monitored 440 randomly selected high-risk patients over a six-month period, analyzing blood glucose control and high blood glucose index. After just one month of use of the app, the mean blood glucose was drastically lowered, and after six months of use, the results showed a nearly 20% drop in mean blood glucose.
The study results also showed a significant reduction in the size of the group at high-to-medium risk of severe events by more than 40%.